COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess.

Authors	Rosario Pivonello, Rosario Ferrigno, Andrea M Isidori, Beverly M K Biller, Ashley B Grossman, Annamaria Colao
Journal	The lancet. Diabetes & endocrinology (Lancet Diabetes Endocrinol) Vol. 8 Issue 8 Pg. 654-656 (08 2020) ISSN: 2213-8595 [Electronic] England
PMID	32531251 (Publication Type: Journal Article)
Chemical References	Glucocorticoids
Topics	Betacoronavirus COVID-19 Coronavirus Infections (complications) Cushing Syndrome (complications, immunology) Glucocorticoids (physiology) Humans Pandemics Pneumonia, Viral (complications) SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!